Next Live Webinars

Elevate process, maximize flexibility: advanced QbD and Continuous Manufacturing for moisture-protective coatings

Overview

Join Seppic and IMA teams, in collaboration with Pharma Excipients, for an exclusive webinar exploring how modern process design meets high-performance moisture protection. Formulators often face a trade-off between strict moisture protection and manufacturing efficiency.

This webinar highlights how Sepifilm™ LP overcomes these operational limits, offering unmatched flexibility across both batch and continuous manufacturing setups. Backed by a new Quality by Design (QbD) study, you will learn how this innovative coating delivers consistent, high-performing moisture barrier results while adapting seamlessly to evolving processing technologies.

Key learnings for participants

Enhanced moisture protection: learn how Sepifilm™ LP provides API and sensitive core protection.
Quality by Design (QbD) insights: review new data demonstrating optimized process parameters for consistent, reliable moisture protection.
Continuous manufacturing success: discover real-world processing results and performance metrics that make Sepifilm™ LP unique in continuous operations.

Date & Details

Participation fee: Free of charge
Workshop language: English
Agenda: Nov 16, 2026 04:00 PM in Amsterdam, Berlin, Rome, Stockholm, Vienna

For more information & registration here:

MORE INFORMATION & REGISTRATION

Speaker:

Mathilde Pons

Coatings & Excipients Development Manager, Seppic

LOLA VOIRIN

Coatings Product Manager – Pharma & Nutrition – SEPPIC

Samuele Capomasi

Process Specialist | OSD Process Development, Scale-Up & Technology Transfer

For more information & registration here:

MORE INFORMATION & REGISTRATION

CarboHyde Cyclodextrin Masterclass

Cyclodextrins in Biologics: From Peptides to Antibodies, Vaccines & Oligonucleotides

MORE INFORMATION & REGISTRATION

Biologics are transforming modern medicine — but their size, complexity and sensitivity create some of the toughest challenges in formulation, stability and delivery.

In this masterclass, we will explore how cyclodextrins can contribute to the development and delivery of biologics, from peptides and proteins to antibodies, vaccines and oligonucleotides.

We will look beyond the traditional role of cyclodextrins as solubilizers and formulation excipients and examine their potential as stabilizing agents, delivery components, immune modulators and building blocks for advanced delivery systems.

What will we cover?

Peptides & proteins — formulation and stabilization challenges, and how cyclodextrins can help address them.
Antibodies & biotherapeutics — aggregation, stability and high-concentration formulations, including examples of cyclodextrin-containing approaches investigated with therapeutic antibodies.
Vaccines — cyclodextrins as formulation/stabilization components, cryoprotectants and potential adjuvants. We will discuss real-world examples, including the use of HPβCD in the Janssen COVID-19 vaccine formulation and cyclodextrin-based veterinary vaccines.
Oligonucleotides & nucleic acids — how chemically modified cyclodextrins and CD-based polymers can contribute to the protection, transport and cellular delivery of RNA and other nucleic acids.

Commercial examples & case studies

The masterclass will connect published research with real pharmaceutical applications, highlighting where cyclodextrins have already reached the market and where emerging CD-based technologies are being developed.

We will discuss selected case studies covering vaccine formulations, antibody stabilization and advanced nucleic-acid delivery, including cyclodextrin-based nanovaccine platforms for peptide antigens.

The goal is not simply to review the literature, but to understand where cyclodextrins can genuinely add value in biologics development — and what challenges still need to be solved before promising concepts become products.

Who should attend? – This masterclass is designed for:

Formulation scientists • Drug delivery researchers • Biologics developers • Pharmaceutical R&D teams • CMC scientists • Analytical scientists • Vaccine and RNA developers • Academic researchers • CD specialists

Whether you are already working with cyclodextrins or are exploring them for the first time, this session will provide a practical overview of what CDs can do for biologics — and where the opportunities are next.

Date & Details